For the Inventor, By the Inventor

Enter assignee name

Chicago, IL, United States of America

Tempus Ai, Inc.

USPTO Granted Patents = 20

EPO Patents = 5

Trademarks = 33

Forward Citations = 4

Loading Chart...

Loading Chart...

62 inventors (with patents filed for the assignee):

Jonathan Ozeran (5 out of 16 patents)

Aly Azeem Khan (5 out of 20 patents)

Stephen Yip (3 out of 14 patents)

4. Eric Lefkofsky (3 out of 12 patents)

5. Richard Blidner (2 out of 4 patents)

6. Irvin Ho (2 out of 11 patents)

7. Lingdao Sha (2 out of 11 patents)

8. Boleslaw Osinski (2 out of 11 patents)

9. Andrew J Kruger (2 out of 9 patents)

10. Michael Carlson (2 out of 9 patents)

11. Abel Greenwald (2 out of 9 patents)

12. Caleb Willis (2 out of 9 patents)

13. Jagadish Venkataraman (2 out of 31 patents)

14. Ashraf Hafez (2 out of 11 patents)

15. Nathaniel Braman (2 out of 14 patents)

20 patents: Sort by Forward Citations

1. 12525355 - Systems and methods of radiomics based cancer stratification (2026-01-13),

2. 12525343 - Artificially intelligent routing agent for routing portions of a task through multiple customized agents, and systems, devices, and methods of use thereof (2026-01-13),

3. 12524826 - Determining biomarkers from histopathology slide images (2026-01-13),

4. 12512187 - Sparse N-gram modeling for patient-entity relation extraction (2025-12-30),

5. 12462911 - Clinical concept identification, extraction, and prediction system and related methods (2025-11-04),

6. 12451250 - Systems and methods for predicting therapeutic sensitivity (2025-10-21),

7. 12412665 - Methods for evaluating the effect of the start date for cancer treatment with a cancer medication using propensity scoring (2025-09-09),

8. 12365943 - Systems and methods for next generation sequencing uniform probe design (2025-07-22),

9. 12361542 - Systems and methods for deep orthogonal fusion for multimodal prognostic biomarker discovery (2025-07-15),

10. 12271832 - Artificial intelligence engine for directed hypothesis generation and ranking (2025-04-08),

11. 12217429 - 3D radiomic platform for imaging biomarker development (2025-02-04),

12. 12203139 - Systems and methods for detecting multi-molecule biomarkers (2025-01-21),

13. 12190884 - Collaborative artificial intelligence method and system (2025-01-07),

14. 12165753 - Systems and methods for interrogating clinical documents for characteristic data (2024-12-10),

15. 12165236 - Predicting total nucleic acid yield and dissection boundaries for histology slides (2024-12-10),

Tempus Ai, Inc. is an innovative technology company specializing in artificial intelligence and machine learning solutions. Founded to harness the power of data analytics, Tempus Ai aims to improve decision-making processes across various sectors by providing cutting-edge AI tools. Their services include data integration, predictive modeling, and advanced analytics that empower businesses to optimize their operations. With a focus on healthcare, finance, and manufacturing industries, Tempus Ai utilizes proprietary algorithms and cloud-based platforms to deliver actionable insights that drive efficiency and growth. The team's expertise and commitment to excellence position Tempus Ai as a leader in the AI landscape, dedicated to transforming industries through technology.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 20 2026

20 Patents

#189 in Chicago, IL

#810 in Illinois

#15,918 in US

#30,410 in the World

Chicago, IL, United States of America

Tempus Ai, Inc.

Forward Citations = 4

62 inventors:

Jonathan Ozeran (5 out of 16 patents)

Aly Azeem Khan (5 out of 20 patents)

Stephen Yip (3 out of 14 patents)

4. Eric Lefkofsky (3 out of 12 patents)

5. Richard Blidner (2 out of 4 patents)

Please report any incorrect information to support@idiyas.com

Loading…